Kolja I. Ortmann

Associate

Portrait backdrop

Brussels

+32-2896-8000

Frankfurt

+49-69-4272-5200

|

ortmannk@sullcrom.com

Email vCard

Spotlight

S&C Advises Flix as EQT Future and Kühne Holding Acquire 35 Percent Stake

S&C Helps Seagen Obtain Global Antitrust and Regulatory Clearances for $43 Billion Acquisition by Pfizer

News

S&C Advises Baxter in $3.8 Billion Sale of Vantive Kidney Care Segment to Carlyle
August 15, 2024
S&C Advises Lundin Mining in Joint Acquisition of Filo for C$4.1 Billion
August 14, 2024
S&C Advises Flix as EQT Future and Kühne Holding Acquire 35 Percent Stake
July 8, 2024
S&C Advises Boeing in $8.3 Billion Acquisition of Spirit AeroSystems
July 1, 2024
S&C Helps Seagen Obtain Global Antitrust and Regulatory Clearances for $43 Billion Acquisition by Pfizer
December 19, 2023
S&C Advises Amgen in Obtaining FTC and Global Clearances of Its $27.8 Billion Acquisition of Horizon Therapeutics, Leading to Deal’s Closing
October 13, 2023

Read More

Read More

Credentials

Education

Harvard Law School, J.D., 2019
University of Cambridge, M.Phil, 2014
Imperial College London, B.Sc., 2012

Bar Admissions

Brussels, Belgium (B-List)
District of Columbia
Ireland
New York

Languages

English
German

Read More

Related Practices